National Health (June 2026 First New Brand Statutory Price Reduction) (Exercise of Ministerial discretion) Determination 2026

PB 45 of 2026

National Health (June 2026 First New Brand Statutory Price Reduction) (Exercise of Ministerial discretion) Determination 2026

1  Name

 (1) This instrument is the National Health (June 2026 First New Brand Statutory Price Reduction) (Exercise of Ministerial discretion) Determination 2026.

   (2) This instrument may also be cited as PB 45 of 2026.

2  Commencement

  This instrument commences on 1 June 2026.

3  Authority

  This instrument is made under sections 99ACB and 99ACD of the National Health Act 1953.

4  Definitions

 Note: A number of expressions used in this instrument are defined in Part VII the Act.

In this instrument:

Act means the National Health Act 1953.

Reduction day refers to 1 June 2026.

5  Brands of pharmaceutical item (combination items) not subject to a price reduction

1.     I determine under paragraph 99ACD(7A)(a) of the Act that the agreed price of the brand of pharmaceutical item specified in item 1 in the table in Part 1 of Schedule 1 that comes into force on the reduction day is to be equal to the approved ex‑manufacturer price, on the day before the determination day, of the listed brands of the existing item. 

6  Brands of pharmaceutical item (not combination items) not subject to a price reduction

1.     I determine under paragraph 99ACB(6A)(a) of the Act that the agreed price of the brand of pharmaceutical item specified in item 1 in the table in Part 1 of Schedule 2 that comes into force on the reduction day is to be equal to the approved ex‑manufacturer price, on the day before the determination day, of the listed brands of the existing item. 

Schedule 1 Brands of pharmaceutical item (combination items) not subject to a price reduction

Part 1

Schedule 2 Brands of pharmaceutical item (not combination items) not subject to a price reduction

Part 1